MARATTO

article · Scandinavian Journal of Infectious Diseases

The first Bundibugyo virus vaccine trial: from first-in-human testing to outbreak readiness

Abstract

On July 24, 2026, Oxford reported administering ChAdOx1 BDBV to the first participant in BD-Ebov, the first Phase I trial of a vaccine designed specifically against Bundibugyo virus. This single-ce...

Research topics

  • Mosquito-borne diseases and control
  • Vector-Borne Animal Diseases
  • Viral Infections and Outbreaks Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/23744235.2026.2717159

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.